| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Medical Research Council Human Reproductive Sciences Unit, Center for Reproductive Biology, University of Edinburgh (P.B., G.A.S., J.T., R.A.L.B., P.T.K.S., R.A.A.); and Endocrinology Unit, Molecular Medicine Center, Western General Hospital (J.R.S.), Edinburgh, United Kingdom EH16 4SB
Address all correspondence and requests for reprints to: Dr. Richard A. Anderson, Medical Research Council Human Reproductive Sciences Unit, Center for Reproductive Biology, University of Edinburgh Chancellors Building, 49 Little France Crescent, Edinburgh, United Kingdom EH16 4SB. E-mail: r.a.anderson{at}hrsu.mrc.ac.uk.
Mutations in the DAX-1 (NROB1) gene result in X-linked congenital adrenal hypoplasia (AHC) and hypogonadotropic hypogonadism. The clinical presentation is usually as adrenal insufficiency in early life, with hypogonadotropic hypogonadism detected at the time of expected puberty. In this study we identified mutations in the DAX-1 gene of two patients with AHC. One mutation, Y399X, resulted in a premature stop codon and was associated with loss of Leydig cell responsiveness to human chorionic gonadotropin. The second, L297P, was a missense mutation, and human chorionic gonadotropin responsiveness was maintained. Kindred analysis established that the mutations had been inherited from the probands mothers. The L297P has not been described previously and occurs within a highly conserved binding motif (LLXLXL). Transient transfection assays demonstrated that both mutations resulted in a severe loss of DAX-1 repressor activity. Immunohistochemical analysis of testicular tissue obtained from an affected sibling of the subject with the Y399X mutation, who had died with adrenal failure as a neonate, showed normal testicular morphology and expression of DAX-1, steroidogenic factor-1, and anti-Mullerian hormone protein. These data extend the clinical and molecular information on DAX-1 mutations, confirm normal testicular development at the neonatal stage, and illustrate variability in Leydig cell function.
Abbreviations: AHC, Congenital adrenal hypoplasia; AMH, anti-Mullerian hormone; hCG, human chorionic gonadotropin; LUC, luciferase; SF-1, steroidogenic factor-1.
This article has been cited by other articles:
![]() |
S. Maudsley, Z. Naor, D. Bonfil, L. Davidson, D. Karali, A. J. Pawson, R. Larder, C. Pope, N. Nelson, R. P. Millar, et al. Proline-Rich Tyrosine Kinase 2 Mediates Gonadotropin-Releasing Hormone Signaling to a Specific Extracellularly Regulated Kinase-Sensitive Transcriptional Locus in the Luteinizing Hormone {beta}-Subunit Gene Mol. Endocrinol., May 1, 2007; 21(5): 1216 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lin, W.-X. Gu, G. Ozisik, W. S. To, C. J. Owen, J. L. Jameson, and J. C. Achermann Analysis of DAX1 (NR0B1) and Steroidogenic Factor-1 (NR5A1) in Children and Adults with Primary Adrenal Failure: Ten Years' Experience J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3048 - 3054. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mantovani, E. De Menis, G. Borretta, G. Radetti, S. Bondioni, A. Spada, L. Persani, and P. Beck-Peccoz DAX1 and X-linked adrenal hypoplasia congenita: clinical and molecular analysis in five patients. Eur. J. Endocrinol., May 1, 2006; 154(5): 685 - 689. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |